Skip to main content
. Author manuscript; available in PMC: 2021 Aug 26.
Published in final edited form as: J Drug Deliv Sci Technol. 2020 Sep 28;61:102117. doi: 10.1016/j.jddst.2020.102117

Table 1.

The IC50s of the treatments (μg/mL).

Cell lines Imatinib GQD GQDs@imatiniba
RPMI 8226 32.61 991.1 93.59
NCI-ADR/RES 41.35 849.2 88.93
a

Equivalent imatinib dose.